Suppr超能文献

使用轨道旋切术进行原位微通道再通作为TASC II D型主髂动脉闭塞性疾病标准再通失败后的可行替代方案。

Native Microchannel Recanalization with Orbital Atherectomy as a Viable Alternative to Failed Standard Recanalization of TASC II D Aortoiliac Occlusive Disease.

作者信息

Kiang Sharon C, Boggs Hans K, Abou-Zamzam Ahmed M, Tomihama Roger T

机构信息

Division of Vascular Surgery, Department of Surgery, Linda University School of Medicine, Loma Linda, CA; Division of Vascular Surgery, Department of Surgery, VA Loma Linda Healthcare System, Loma Linda, CA.

Division of Vascular Surgery, Department of Surgery, Linda University School of Medicine, Loma Linda, CA.

出版信息

Ann Vasc Surg. 2020 May;65:45-53. doi: 10.1016/j.avsg.2020.01.076. Epub 2020 Jan 28.

Abstract

BACKGROUND

Endovascular treatment of Trans-Atlantic Inter-Society Consensus (TASC) II D aortoiliac lesions is now an accepted form of revascularization. We sought to demonstrate that native microchannel recanalization and orbital atherectomy is a successful recanalization method of TASC II D aortoiliac lesions refractory to standard recanalization techniques.

METHODS

Four consecutive patients from 2016 to 2018 with symptomatic TASC II D aortoiliac occlusive disease prohibitive for open bypass and failed traditional prodding guidewire or device recanalization technique were identified and underwent advanced native microchannel selection and subsequent orbital atherectomy (Cardiovascular Systems, Inc, St Paul, MN). Native microchannels of the calcified lesions were probed and traversed with a 0.014″ wire. The atherectomy crown was tracked over the wire, and orbital atherectomy was initiated with a 1.25 mm crown starting at the lowest revolution and continued until the microchannel is sufficiently large to track a 1.2 mm-balloon for angioplasty. Serial microchannel angioplasty with exchange for stiffer and/or larger profile wires and balloons was achieved until a covered stent could be safely deployed across the target lesion. The kissing stent technique was then used to recreate the aortic bifurcation. A ViperSlide lubricant solution was used in all cases per indication for use. Patients were all heparinized to maintain an activated clotting time of 250. Lesion characteristics, survival, limb salvage, patency, and change in clinical symptoms were also analyzed.

RESULTS

All 4 patients underwent successful native microchannel recanalization and orbital atherectomy of the common iliac artery (CIA). There were no intraoperative ruptures, embolizations, or dissections. All 4 patients presented with unilateral CIA occlusion with contralateral CIA stenosis. The average occlusion lesion length of the CIA was 6.0 cm. The average contralateral stenosis length was 2.3 cm. The kissing stent technique was used in all patients for reconstruction of the aortic bifurcation. At 30 days, all patients had improvement in pain and primary patency of 100%. Long-term follow-up at 21.6 months noted continued improvement in symptoms and primary patency of 75%. The fourth patient died at 4 months from lung cancer with occluded iliac stents by imaging at that time.

CONCLUSIONS

Native microchannel recanalization with subsequent orbital atherectomy is an option in high-risk patients with TASC II D aortoiliac disease who have failed traditional recanalization techniques. Further work in proper patient selection and safe utilization of atherectomy devices in the CIA is needed.

摘要

背景

跨大西洋两岸血管外科学会(TASC)II D型主髂动脉病变的血管腔内治疗现已成为一种被认可的血管重建方式。我们试图证明,原位微通道再通和轨道旋切术是一种成功的再通方法,可用于标准再通技术难以处理的TASC II D型主髂动脉病变。

方法

确定了2016年至2018年连续4例有症状的TASC II D型主髂动脉闭塞性疾病患者,这些患者因无法进行开放旁路手术且传统的引导钢丝或器械再通技术失败而接受了先进的原位微通道选择及随后的轨道旋切术(心血管系统公司,明尼苏达州圣保罗)。用0.014英寸的导丝探测并穿过钙化病变的原位微通道。旋切头沿导丝送入,从最低转速开始用1.25毫米的旋切头进行轨道旋切术,持续进行直至微通道足够大,能够送入1.2毫米的球囊进行血管成形术。通过依次更换更硬和/或更大尺寸的导丝及球囊进行微通道血管成形术,直至能够安全地在目标病变处植入覆膜支架。然后采用双吻合法支架技术重建主动脉分叉。所有病例均根据使用说明使用ViperSlide润滑溶液。所有患者均接受肝素化治疗,以维持活化凝血时间为250秒。还分析了病变特征、生存率、肢体挽救情况、通畅率及临床症状的变化。

结果

所有4例患者均成功进行了原位微通道再通及髂总动脉(CIA)的轨道旋切术。术中无破裂、栓塞或夹层形成。所有4例患者均表现为单侧CIA闭塞,对侧CIA狭窄。CIA闭塞病变的平均长度为6.0厘米。对侧狭窄的平均长度为2.3厘米。所有患者均采用双吻合法支架技术重建主动脉分叉。30天时,所有患者的疼痛均有改善,一期通畅率为100%。21.6个月的长期随访显示症状持续改善,一期通畅率为75%。第四例患者在4个月时死于肺癌,当时影像学检查显示髂动脉支架闭塞。

结论

对于传统再通技术失败的TASC II D型主髂动脉疾病高危患者,原位微通道再通及随后的轨道旋切术是一种选择。需要在合适的患者选择以及CIA中旋切装置的安全使用方面做进一步的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验